Femasys Inc. (FEMY) Operating Margin
- Operating margin · 12 months: Value -763.90%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -763.90% | Operating income / revenue. Period ending 2026-06-30. $-17.57M ÷ $2.30M × 100 ≈ -763.90% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -17.57M USD | Operating Income (Loss) |
| Revenue | 2.30M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 898.00K USD | Cost of Goods and Services Sold |
| Research and development | 6.45M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-17.57M | $2.30M | $898.00K | $6.45M | (m) | -763.90% |
| 2026-03-31 | $-16.35M | $2.38M | $913.74K | $5.92M | (m) | -687.93% |
| 2025-12-31 | $-17.59M | $2.29M | $872.40K | $7.58M | (m) | -766.95% |
| 2025-09-30 | $-17.69M | $2.06M | $761.68K | $7.93M | (m) | -858.04% |
| 2025-06-30 | $-19.15M | $1.89M | $658.68K | $8.85M | (m) | -1015.00% |
| 2025-03-31 | $-19.78M | $1.70M | $573.64K | $9.41M | (m) | -1164.28% |
| 2024-12-31 | $-17.79M | $1.63M | $544.90K | $8.22M | (m) | -1091.75% |
| 2024-09-30 | $-17.51M | $1.26M | $430.79K | $8.12M | (m) | -1389.19% |
| 2024-06-30 | $-16.48M | $950.10K | $326.14K | $7.89M | (m) | -1734.10% |
| 2024-03-31 | $-14.93M | $1.05M | $363.48K | $7.44M | (m) | -1423.03% |
| 2023-12-31 | $-14.51M | $1.07M | $380.07K | $7.21M | (m) | -1353.43% |
| 2023-09-30 | $-13.06M | $1.09M | $387.23K | $6.41M | (m) | -1194.70% |
| 2023-06-30 | $-12.04M | $1.20M | $432.50K | $5.98M | (m) | -1006.12% |
| 2023-03-31 | $-11.76M | $1.18M | $424.38K | $5.93M | (m) | -997.56% |
| 2022-12-31 | $-11.60M | $1.21M | $441.94K | $5.81M | (m) | -961.71% |
| 2022-09-30 | $-10.96M | $1.23M | $420.79K | $5.60M | (m) | -893.55% |
| 2022-06-30 | $-10.15M | $1.15M | $394.74K | $5.09M | (m) | -883.98% |
| 2022-03-31 | $-9.39M | $1.17M | $400.02K | $4.51M | (m) | -801.92% |
| 2021-12-31 | $-8.34M | $1.18M | $370.38K | $4.08M | (m) | -706.70% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-6.93M | $1.04M | $306.53K | $4.13M | (m) | -667.99% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |